Type 1 diabetes screening is clearer now for higher-risk families

The CDC says type 1 diabetes can develop in stages long before a person needs insulin, and that people at higher risk may benefit from screening before symptoms begin. For families with a close relative who has type 1 diabetes, the new guidance is meant to make that process easier to understand and easier to discuss with a clinician.

This is not a one-size-fits-all diagnosis or a promise of prevention. It is a way to find early signs sooner, so families and clinicians can watch for symptoms, repeat testing when needed, and act quickly if blood sugar problems start.

What changed

In its April 17, 2026 update, the CDC highlighted that type 1 diabetes develops in stages and may start well before symptoms. The agency says screening can be useful for people at higher risk, especially because type 1 diabetes is often first found during a medical emergency such as diabetic ketoacidosis, or DKA.

The American Diabetes Association’s 2026 Standards of Care also note expanded screening and monitoring guidance for people at risk for type 1 diabetes. Together, these updates reinforce a shift toward earlier recognition, not just diagnosis after symptoms appear.

Who should ask about screening

A family history of type 1 diabetes raises risk, and the CDC says people with a family member who has type 1 diabetes should be offered screening. But family history is not required for someone to develop type 1 diabetes, so it is not the only factor clinicians consider.

Screening can begin at age 2, according to the CDC. In some cases, families without a known family history may still discuss screening if there are other reasons for concern.

What the results can mean

Type 1 diabetes screening looks for diabetes-related autoantibodies in blood. The CDC describes three broad result patterns:

Negative: no autoantibodies are found. There is currently no set guidance on when to repeat screening after a negative result.
One confirmed autoantibody: this suggests a person is at risk and may need follow-up monitoring.
Two or more confirmed autoantibodies: this means early-stage type 1 diabetes, even if blood sugar is still normal or symptoms have not started.

Because results can need confirmation, repeat testing matters. That helps reduce the chance of acting on a single test that may not tell the full story.

Why early awareness matters

The CDC says earlier screening can help people notice symptoms sooner and avoid serious complications. That matters because DKA can be life-threatening if untreated, and the CDC notes that 30% to 40% of children are already in DKA when they are first diagnosed with type 1 diabetes.

MedlinePlus says common symptoms of diabetes can include extreme thirst, frequent urination, fatigue, blurry vision, and unplanned weight loss. Type 1 symptoms often come on quickly, which is one reason families may not realize what is happening until a child or adult becomes quite ill.

What readers can do

If type 1 diabetes runs in your family, or if you are worried about symptoms in yourself or a child, talk with a clinician about whether screening makes sense and what follow-up would look like if the result is positive. You can also ask whether repeat monitoring is appropriate over time.

If someone has symptoms of high blood sugar, becomes very drowsy, vomits, has trouble breathing, or seems confused, seek urgent medical care. Those can be signs of DKA or another emergency.

The bottom line

The new CDC guidance is mainly about earlier recognition and clearer follow-up for families at higher risk. It may help some people learn they are in an early stage of type 1 diabetes before a crisis happens, but it does not guarantee prevention and it does not replace a clinician’s judgment.

For everyday readers, the practical step is simple: if type 1 diabetes is in your family, ask whether screening is worth discussing now rather than waiting for symptoms.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.